Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10364266 Compounds

Patent 10364266 was granted and assigned to GlaxoSmithKline on July, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

GlaxoSmithKline

Current Assignee

GlaxoSmithKline

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10364266

Patent Inventor Names

Yiqian Lian0

Jerry Adams0

Date of Patent

July 30, 2019

Patent Application Number

15979729

Date Filed

May 15, 2018

Patent Citations Received

‌

US Patent 11400108 Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

‌

US Patent 10933078 Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

‌

US Patent 11299512 Cyclic di-nucleotide compounds and methods of use

Patent Primary Examiner

‌

Traviss C Mcintosh, III

Patent abstract

A compound of Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10364266 Compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API